DPP4 and COVID-19: Very recent studies also reported that COVID-19 diabetic patients with high DPPIV levels had more severe cerebrovascular events compared to non-diabetic COVID-19 patients, further underlining the pivotal role this enzyme plays in bridging metabolic dysfunction to COVID-19 severity [106].